One of our collaborations speaking at the 21st International...

First 57 Last

Share
Profile

Follow
mattyedw

7,238 Posts.

938

08/04/24

16:17

Post #: 73243154
Share

Originally posted by Fact Finder ↑

“Potential to use Deoxymabs to treat autoimmune diseases to be highlighted at international conferenceMelbourne, Australia; 4 March 2024: Patrys Limited (ASX: PAB, “Patrys” or the “Company”, a therapeutic antibody development company, is pleased to announce that new data from preclinical studies using PAT-DX1 in animal models of anti neutrophil cytoplasmic antibody (ANCA) vasculitis will be presented at the 21st International Vasculitis Workshop in Barcelona next month.The oral presentation by Dr Kim O’Sullivan from Monash University in Melbourne will be held during the plenary session on 8 April 2024 at 9:30am (CET time), and will examine recent pre-clinical studies that demonstrate the potential to ameliorate the underlying processes associated with autoimmune diseases such as ANCA vasculitis.ANCA vasculitis or AAV is an autoimmune disease characterized by the pathological accumulation of activated neutrophils and neutrophil extracellular traps (NETs) within small blood vessels. As current therapies render patients at high risk of serious infections, there is an unmet need for therapies without serious side effects. Patrys Chief Executive Officer and Managing Director, Dr. James Campbell, said: “Our collaboration with Dr Kim O’Sullivan at Monash University has continuted to identify new properties for our deoxymabs that may open up new therapeutic opportunities. The recent studies, which will be presented at the 21st International Vasculitis Workshop in Barcelona to a knowledgable and respected audience of industry peers, have indicated that deoxymabs may have a potential role in the treatment of various inflammatory diseases, and in particular certain types of vasculitis. As GMP manufacturing for PAT-DX1 remains on track to commence in the current quarter, it is exciting to identify additional therapeutic opportunities for our deoxymab platform with promising future partnering and licensing opportunities for Patrys”

Expand

One of our collaborations speaking at the 21st International Vasculitis Workshop in Barcelona, how many more collaborations do we have out there??

MONDAY, 8 APRIL | 08:00-09:45 | ROOM 112
Add to calendar

O-002. Manipulation of the gut microbiome protects from kidney inflammation and injury in experimental myeloperoxidase anti neutrophil cytoplasmic antibody vasculitis.
Speaker: Kim Maree O'Sullivan. Monash University, Melbourne, Australia
---------------------------------------------------

The human trials is obviously very important, but how many things could our IP be connected with for ALL kinds or research/income possibitities ?????????????????

PAB Price at posting: 0.8¢ Sentiment: Buy Disclosure: Held
4 Upvote

1 Great analysis

Reply

There are more pages in this discussion • 33 more messages in this thread...

First 57 Last

Add PAB (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $16.46M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.8¢	$4.95K	618.7K

Buyers (Bids)

No.	Vol.	Price($)
2	839316	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	1550008	2

View Market Depth

No.	Vol.	Price($)
2	839316	0.008
22	6453441	0.007
10	2287680	0.006
8	3155992	0.005
5	4324000	0.004

Price($)	Vol.	No.
0.009	1550008	2
0.010	1610744	3
0.011	1610000	5
0.012	372407	3
0.013	990000	2

Last trade - 14.48pm 06/05/2024 (20 minute delay)

PAB (ASX) Chart

One of our collaborations speaking at the 21st International...

Featured News

Sold out signs go up for RIU Resources Roundup in Sydney

Tamboran is listing on the NYSE, and Wall Street is paying attention

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Mantle Minerals to kick off drilling at Mt Berghaus in WA

Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy

Buyers (Bids)

Sellers (Offers)

Featured News

One of our collaborations speaking at the 21st International...

Featured News

Top Stories

Sold out signs go up for RIU Resources Roundup in Sydney

Tamboran is listing on the NYSE, and Wall Street is paying attention

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Mantle Minerals to kick off drilling at Mt Berghaus in WA

Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy

Buyers (Bids)

Sellers (Offers)

Featured News